NDC 71904-300-01
OPFOLDA 65 mg/1
miglustat · CAPSULE
Miglustat is an oral medication used to treat certain rare inherited metabolic disorders, such as Gaucher disease and Niemann-Pick disease type C, by slowing the buildup of harmful substances in the body. It works by inhibiting an enzyme involved in the production of these damaging compounds.
Key Facts
- Brand Name
- OPFOLDA
- Generic Name
- miglustat
- NDC Code (Package)
71904-300-01- NDC Code (Product)
71904-300- Manufacturer
- AMICUS THERAPEUTICS US, LLC
- Strength
- 65 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA215211
- Drug Class
- Glucosylceramide Synthase Inhibitor [EPC]; Enzyme Stabilizer [EPC]
- Marketing Start
- 10/11/2023
Recall History
No Recall HistoryView Full Drug Page
OPFOLDA — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.